GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Dividend-Payout-to-FFO

Cinclus Pharma Holding AB (OSTO:CINPHA) Dividend-Payout-to-FFO


View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Cinclus Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Kungsbron 1, Stockholm, SWE, SE-111 22
Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.